Effects of the Couplet Care in Neonatal Intensive Care Unit
Launched by TURKU UNIVERSITY HOSPITAL · Dec 8, 2022
Trial Information
Current as of February 05, 2025
Unknown status
Keywords
ClinConnect Summary
Background: It is essential to keep newborn infants and their parents together for the well-being of both. However, the families whose infants need admission to the neonatal intensive care unit (NICU) are often separated. One of the solutions to reduce parent-infant separation is couplet care, where both mother and newborn infant receive their postpartum care in the same hospital room, even if the infant needs intensive care. However, currently only a few NICUs practice couplet care, and the scientific evidence to support implementing couplet care has been scarce. Since moving into the new ...
Gender
ALL
Eligibility criteria
- • \[Family\]
- Inclusion Criteria:
- • Families of preterm infants born below 35 weeks of gestation at Turku University Hospital
- Exclusion Criteria:
- • The expected duration of hospitalization is less than 3 days
- • Outborn infants
- • The infants are triplets or more
- • The parents cannot understand the informed consent form in either Finnish, Swedish, English, or Russian
- • The infant's condition is critical and survival is uncertain
- • \[healthcare staff\]
- Inclusion Criteria:
- • All healthcare staff who have the possibility to participate in the decision about parent-infant early skin-to-skin contact after the delivery.
- Exclusion Criteria:
- • No
Trial Officials
Liisa Lehtonen, MD
Principal Investigator
Turku University Hospital
About Turku University Hospital
Turku University Hospital (TYKS) is a leading academic medical center located in Turku, Finland, renowned for its commitment to advancing healthcare through innovative research and clinical excellence. As a key institution within the University of Turku, TYKS integrates cutting-edge medical education with state-of-the-art clinical services, offering a broad spectrum of specialized care. The hospital actively participates in clinical trials, facilitating the translation of scientific discoveries into practical treatments, and enhancing patient outcomes. With a multidisciplinary approach and a focus on collaboration, TYKS aims to contribute significantly to the global medical community through its rigorous research initiatives and commitment to patient-centered care.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
People applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Discussion 0
Similar Trials